190 related articles for article (PubMed ID: 24438193)
21. Genetic manipulation of primary human natural killer cells to investigate the functional and oncogenic roles of PRDM1.
Dong G; Li Y; Lee L; Liu X; Shi Y; Liu X; Bouska A; Gong Q; Kong L; Wang J; Lou CH; McKeithan TW; Iqbal J; Chan WC
Haematologica; 2021 Sep; 106(9):2427-2438. PubMed ID: 32732362
[TBL] [Abstract][Full Text] [Related]
22. Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling.
Ng SB; Selvarajan V; Huang G; Zhou J; Feldman AL; Law M; Kwong YL; Shimizu N; Kagami Y; Aozasa K; Salto-Tellez M; Chng WJ
J Pathol; 2011 Mar; 223(4):496-510. PubMed ID: 21294123
[TBL] [Abstract][Full Text] [Related]
23. NF-kappaB activation through the alternative pathway correlates with chemoresistance and poor survival in extranodal NK/T-cell lymphoma, nasal type.
Liu X; Wang B; Ma X; Guo Y
Jpn J Clin Oncol; 2009 Jul; 39(7):418-24. PubMed ID: 19395464
[TBL] [Abstract][Full Text] [Related]
24. RUNX3 is oncogenic in natural killer/T-cell lymphoma and is transcriptionally regulated by MYC.
Selvarajan V; Osato M; Nah GSS; Yan J; Chung TH; Voon DC; Ito Y; Ham MF; Salto-Tellez M; Shimizu N; Choo SN; Fan S; Chng WJ; Ng SB
Leukemia; 2017 Oct; 31(10):2219-2227. PubMed ID: 28119527
[TBL] [Abstract][Full Text] [Related]
25. JAK3/STAT3 oncogenic pathway and PRDM1 expression stratify clinicopathologic features of extranodal NK/T‑cell lymphoma, nasal type.
Liu J; Liang L; Li D; Nong L; Zheng Y; Huang S; Zhang B; Li T
Oncol Rep; 2019 Jun; 41(6):3219-3232. PubMed ID: 31002364
[TBL] [Abstract][Full Text] [Related]
26. Blimp-1/PRDM1 regulates the transcription of human CS1 (SLAMF7) gene in NK and B cells.
Kim JR; Mathew SO; Mathew PA
Immunobiology; 2016 Jan; 221(1):31-9. PubMed ID: 26310579
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus-encoded miR-BART20-5p inhibits T-bet translation with secondary suppression of p53 in invasive nasal NK/T-cell lymphoma.
Lin TC; Liu TY; Hsu SM; Lin CW
Am J Pathol; 2013 May; 182(5):1865-75. PubMed ID: 23608226
[TBL] [Abstract][Full Text] [Related]
28. Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses.
Karube K; Nakagawa M; Tsuzuki S; Takeuchi I; Honma K; Nakashima Y; Shimizu N; Ko YH; Morishima Y; Ohshima K; Nakamura S; Seto M
Blood; 2011 Sep; 118(12):3195-204. PubMed ID: 21690554
[TBL] [Abstract][Full Text] [Related]
29. [CD16 expression is an independent prognostic factor for extranodal NK/T cell lymphoma of nasal type].
Zuo Z; Yang QP; Tang Y; Zhao S; Yu JB; Liu YM; Gao LM; Liu WP
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):227-33. PubMed ID: 23928528
[TBL] [Abstract][Full Text] [Related]
30. Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma.
Xia Y; Xu-Monette ZY; Tzankov A; Li X; Manyam GC; Murty V; Bhagat G; Zhang S; Pasqualucci L; Visco C; Dybkaer K; Chiu A; Orazi A; Zu Y; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Møller MB; Parsons BM; Winter JN; Piris MA; Westin J; Fowler N; Miranda RN; Ok CY; Li Y; Li J; Medeiros LJ; Young KH
Leukemia; 2017 Mar; 31(3):625-636. PubMed ID: 27568520
[TBL] [Abstract][Full Text] [Related]
31. Expression of programmed cell death 1 and programmed cell death ligand 1 in extranodal NK/T-cell lymphoma, nasal type.
Jo JC; Kim M; Choi Y; Kim HJ; Kim JE; Chae SW; Kim H; Cha HJ
Ann Hematol; 2017 Jan; 96(1):25-31. PubMed ID: 27696202
[TBL] [Abstract][Full Text] [Related]
32. Increased expression of Trop2 correlates with poor survival in extranodal NK/T cell lymphoma, nasal type.
Chen R; Lu M; Wang J; Zhang D; Lin H; Zhu H; Zhang W; Xiong L; Ma J; Mao Y; Zhu J; Xu J
Virchows Arch; 2013 Nov; 463(5):713-9. PubMed ID: 23979406
[TBL] [Abstract][Full Text] [Related]
33. Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphoma.
Ng SB; Yan J; Huang G; Selvarajan V; Tay JL; Lin B; Bi C; Tan J; Kwong YL; Shimizu N; Aozasa K; Chng WJ
Blood; 2011 Nov; 118(18):4919-29. PubMed ID: 21921041
[TBL] [Abstract][Full Text] [Related]
34. Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp-1 expression for epigenetic modulation of antibody and autoantibody responses.
White CA; Pone EJ; Lam T; Tat C; Hayama KL; Li G; Zan H; Casali P
J Immunol; 2014 Dec; 193(12):5933-50. PubMed ID: 25392531
[TBL] [Abstract][Full Text] [Related]
35. [Potential mechanism and prognostic value of promoter methylation of PRDM1 gene in diffuse large B cell lymphoma].
Zhang XY; Ma ZP; Cui WL; Chen R; Glinaer A; Miao N; Li XX
Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):831-837. PubMed ID: 28056297
[No Abstract] [Full Text] [Related]
36. Beclin 1 expression: a predictor of prognosis in patients with extranodal natural killer T-cell lymphoma, nasal type.
Huang JJ; Li HR; Huang Y; Jiang WQ; Xu RH; Huang HQ; Lv Y; Xia ZJ; Zhu XF; Lin TY; Li ZM
Autophagy; 2010 Aug; 6(6):777-83. PubMed ID: 20639699
[TBL] [Abstract][Full Text] [Related]
37. Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer/T-cell lymphoma: a potential rationale for immunotherapy.
Nagato T; Ohkuri T; Ohara K; Hirata Y; Kishibe K; Komabayashi Y; Ueda S; Takahara M; Kumai T; Ishibashi K; Kosaka A; Aoki N; Oikawa K; Uno Y; Akiyama N; Sado M; Takei H; Celis E; Harabuchi Y; Kobayashi H
Cancer Immunol Immunother; 2017 Jul; 66(7):877-890. PubMed ID: 28349165
[TBL] [Abstract][Full Text] [Related]
38. Cutaneous extranodal natural killer/T-cell lymphoma: a comparative clinicohistopathologic and survival outcome analysis of 45 cases according to the primary tumor site.
Lee WJ; Jung JM; Won CH; Chang SE; Choi JH; Chan Moon K; Park CS; Huh J; Lee MW
J Am Acad Dermatol; 2014 Jun; 70(6):1002-9. PubMed ID: 24629518
[TBL] [Abstract][Full Text] [Related]
39. [Impact of PRDM1 gene inactivation on C-MYC regulation in diffuse large B-cell lymphoma].
Zhang XY; Ma ZP; Cui WL; Pang XL; Chen R; Wang L; Zhang W; Li XX
Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):25-31. PubMed ID: 29325247
[No Abstract] [Full Text] [Related]
40. Establishment and Characterization of a CD20-Positive NK/T-Cell Lymphoma Cell Line.
Gu L; Hong L; Ling Z; Feng J; Zheng Z; Du L; Mou H; Sun W; Kong X; Ling Y; Jiang Z; Zhu C; Mao W; Qian L
Clin Lab; 2015; 61(7):731-9. PubMed ID: 26299072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
